We are live on
!
Find out more
AstraZeneca
AZN
AZN
449 hedge funds and large institutions have $10.8B invested in AstraZeneca in 2016 Q3 according to their latest regulatory filings, with 82 funds opening new positions, 154 increasing their positions, 120 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
308% more call options, than puts
Call options by funds: $138M | Put options by funds: $33.7M
228% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 25
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
28% more repeat investments, than reductions
Existing positions increased: 154 | Existing positions reduced: 120
24% more capital invested
Capital invested by funds: $8.72B → $10.8B (+$2.1B)
13% more funds holding
Funds holding: 397 → 449 (+52)
1.66% more ownership
Funds ownership: 11.43% → 13.09% (+1.7%)
Holders
449
Holders Change
+52
Holders Change %
+13.1%
% of All Funds
11.98%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.19%
New
82
Increased
154
Reduced
120
Closed
25
Calls
$138M
Puts
$33.7M
Net Calls
+$104M
Net Calls Change
+$35.1M
Top Buyers
Top Sellers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$212M |
| 2 |
CI
Cambiar Investors
Denver,
Colorado
|
-$93.2M |
| 3 |
JP Morgan Chase
New York
|
-$42.5M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$31.8M |
| 5 |
HI
Honeywell International
Charlotte,
North Carolina
|
-$25.4M |
